• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/5/21 2:23:42 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care
    Get the next $INFU alert in real time by email
    SC 13G/A 1 infusystem13ga3v2.htm INFUSYSTEM 13G-A3 MINERVA sc13g

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. 3)*

    InfuSystem Holdings, Inc.
    (Name of Issuer)
    Common Stock, $0.0001 Par Value
    (Title of Class of Securities)
    45685K102
    (CUSIP Number)
    January 4, 2021
    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

         [  ]  Rule 13d-1(b)

         [X]   Rule 13d-1(c)

         [  ]   Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

     
                         
    CUSIP No.
     
    45685K102

               
    1   NAMES OF REPORTING PERSONS:
       
      Minerva Advisors LLC
    Minerva Group, LP
    Minerva GP, LP
    Minerva GP, Inc.
    David P. Cohen
     
         
    2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

      (a)    [   ]
      (b)    [   ]
       
         
    3   SEC USE ONLY:
       
       
         
    4   CITIZENSHIP OR PLACE OF ORGANIZATION:
       
      Minerva Advisors LLC - Delaware
    Minerva Group, LP - Delaware
    Minerva GP, LP - Delaware
    Minerva GP, Inc. - Pennsylvania
    David P. Cohen - U.S. Citizen
       
           
    NUMBER OF
    SHARES
    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING
    PERSON
    WITH:
    5   SOLE VOTING POWER:
       
     

    Minerva Advisors LLC* - 783,880
    Minerva Group, LP - 783,880
    Minerva GP, LP* - 783,880
    Minerva GP, Inc.* - 783,880
    David P. Cohen* - 783,880

    *Each of these reporting persons is deemed a beneficial owner of the 783,880 shares of the Issuer held by Minerva Group, LP.

       
         
    6   SHARED VOTING POWER:
       
     

    Minerva Advisors LLC - 209,084
    David P. Cohen** - 209,084

    **David P. Cohen is deemed a beneficial owner of the 209,084 shares of the Issuer beneficially owned by Minerva Advisors LLC.

       
         
    7   SOLE DISPOSITIVE POWER:
       
     

    Minerva Advisors LLC* - 783,880
    Minerva Group, LP - 783,880
    Minerva GP, LP* - 783,880
    Minerva GP, Inc.* - 783,880
    David P. Cohen* - 783,880

    *Each of these reporting persons is deemed a beneficial owner of the 783,880 shares of the Issuer held by Minerva Group, LP.

       
         
    8   SHARED DISPOSITIVE POWER:
       
     

    Minerva Advisors LLC - 209,084
    David P. Cohen** - 209,084

    **David P. Cohen is deemed a beneficial owner of the 209,084 shares of the Issuer beneficially owned by Minerva Advisors LLC.

       
         
    9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
       
      Minerva Advisors LLC* - 992,964
    Minerva Group, LP - 783,880
    Minerva GP, LP* - 783,880
    Minerva GP, Inc.* - 783,880
    David P. Cohen* - 992,964

    *Each of these reporting persons is deemed a beneficial owner of the 783,880 shares of the Issuer held by Minerva Group, LP.  David P. Cohen is also deemed a beneficial owner of the 992,964 shares of the Issuer beneficially owned by Minerva Advisors LLC.

       
         
    10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
       
       [   ]
       
         
    11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
       
     

    Minerva Advisors LLC* - 4.9%
    Minerva Group, LP - 3.9%
    Minerva GP, LP* - 3.9%
    Minerva GP, Inc.* - 3.9%
    David P. Cohen* - 4.9%

    *Each of these reporting persons is deemed a beneficial owner of the 3.9% of the shares of the Issuer held by Minerva Group, LP.  David P. Cohen is also deemed a beneficial owner of the 4.9% of the shares of the Issuer beneficially owned by Minerva Advisors LLC.

    Based on a total of 20,236,932 shares of the Issuer's Common Stock outstanding as of November 6, 2020, as reported in the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2020.

       
         
    12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
       
      Minerva Advisors LLC - IA
    Minerva Group, LP - PN
    Minerva GP, LP - PN
    Minerva GP, Inc. - CO
    David P. Cohen - IN

    SCHEDULE 13G
         
    Item 1(a)
    Name of Issuer.
     
       
    InfuSystem Holdings, Inc.
     
       
    Item 1(b)
    Address of Issuer's Principal Executive Offices.
     
       
    31700 Research Park Drive
    Madison Heights, MI 48071
     
       
    Item 2(a)
    Name of Person Filing.
     
       
    Minerva Advisors LLC
    Minerva Group, LP
    Minerva GP, LP
    Minerva GP, Inc.
    David P. Cohen
     
       
    Item 2(b)
    Address of Principal Business Office or, if none, Residence.
     
       
    50 Monument Road, Suite 201
    Bala Cynwyd, PA 19004
     
       
    Item 2(c)
    Citizenship.
     
       
    David P. Cohen is a U.S. Citizen.
    Minerva Advisors LLC, Minerva Group, LP, and Minerva GP, LP are organized under Delaware law.
    Minerva GP, Inc. is organized under Pennsylvania law.
     
     
       
    Item 2(d)
    Title of Class of Securities.
     
       
    Common Stock, $0.0001 Par Value
     
       
    Item 2(e)
    CUSIP Number.
     
       
    4568K102
         
    Item 3   This statement is not filed pursuant to Rules 13d-1(b), 13d-2(b) or 13d-2(c).
     
       
     
     
    Item 4   Ownership.
     
         
      (a) Amount beneficially owned:

    Minerva Advisors LLC* - 992,964
    Minerva Group, LP - 783,880
    Minerva GP, LP* - 783,880
    Minerva GP, Inc.* - 783,880
    David P. Cohen* - 992,964

    *Each of these reporting persons is deemed a beneficial owner of the 783,880 shares of the Issuer held by Minerva Group, LP.  David P. Cohen is also deemed a beneficial owner of the 992,964 shares of the Issuer beneficially owned by Minerva Advisors LLC.

     
      (b) Percent of Class:

    Minerva Advisors LLC* - 4.9%
    Minerva Group, LP - 3.9%
    Minerva GP, LP* - 3.9%
    Minerva GP, Inc.* - 3.9%
    David P. Cohen* - 4.9%

    *Each of these reporting persons is deemed a beneficial owner of the 3.9% of the shares of the Issuer held by Minerva Group, LP.  David P. Cohen is also deemed a beneficial owner of the 4.9% of the shares of the Issuer beneficially owned by Minerva Advisors LLC.

    Based on a total of 20,236,932 shares of the Issuer's Common Stock outstanding as of November 6, 2020, as reported in the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2020.

     
      (c)

    Number of Shares as to which the person has:

    (i) Sole power to vote or to direct the vote:

    Minerva Advisors LLC* - 783,880
    Minerva Group, LP - 783,880
    Minerva GP, LP* - 783,880
    Minerva GP, Inc.* - 783,880
    David P. Cohen* - 783,880

    *Each of these reporting persons is deemed a beneficial owner of the 783,880 shares of the Issuer held by Minerva Group, LP.

    (ii) Shared power to vote or to direct the vote:

    Minerva Advisors LLC - 209,084
    David P. Cohen** - 209,084

    **David P. Cohen is deemed a beneficial owner of the 209,084 shares of the Issuer beneficially owned by Minerva Advisors LLC.

    (iii) Sole power to dispose or to direct the disposition of:

    Minerva Advisors LLC* - 783,880
    Minerva Group, LP - 783,880
    Minerva GP, LP* - 783,880
    Minerva GP, Inc.* - 783,880
    David P. Cohen* - 783,880

    *Each of these reporting persons is deemed a beneficial owner of the 783,880 shares of the Issuer held by Minerva Group, LP.

    (iv) Shared power to dispose or to direct the disposition of:

    Minerva Advisors LLC - 209,084
    David P. Cohen** - 209,084

    **David P. Cohen is deemed a beneficial owner of the 209,084 shares of the Issuer beneficially owned by Minerva Advisors LLC.

     
    Item 5   Ownership of Five Percent or Less of a Class.
     
        This statement is being filed to report the fact that, as of the date hereof, the reporting persons have ceased to be the beneficial owner of more than 5 percent of the class of securities.
     
    Item 6   Ownership of More Than Five Percent on Behalf of Another Person.
     
        Not applicable.
     
    Item 7   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported On By the Parent Holding Company or Control Person.
     
        Not applicable.
     
    Item 8   Identification and Classification of Members of the Group.
     
        Not applicable.
     
    Item 9   Notice of Dissolution of Group.
     
        Not applicable.
     
    Item 10   Certification.
     
        By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


     
    SIGNATURE
         After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
         
        MINERVA ADVISORS LLC
        Date: February 5, 2021
     
               
        By:   David P. Cohen, President
     
               
            By:   /s/ Beth N. Lowson
               
                Name: Beth N. Lowson
                Title: Attorney-In-Fact
                The Nelson Law Firm, LLC
                445 Hamilton Avenue
                Suite 1102
                White Plains, NY 10601
                 
        MINERVA GROUP, LP
        Date: February 5, 2021
     
               
        By:   MINERVA GP, LP, its General Partner
     
               
        By:   MINERVA GP, INC., its General Partner
     
               
        By:   David P. Cohen, President
                 
            By:   /s/ Beth N. Lowson
               
                Name: Beth N. Lowson
                Title: Attorney-In-Fact
                The Nelson Law Firm, LLC
                445 Hamilton Avenue
                Suite 1102
                White Plains, NY 10601
                 
        MINERVA GP, LP
        Date: February 5, 2021
     
               
        By:   MINERVA GP, INC., its General Partner
     
               
        By:   David P. Cohen, President
                 
            By:   /s/ Beth N. Lowson
               
                Name: Beth N. Lowson
                Title: Attorney-In-Fact
                The Nelson Law Firm, LLC
                445 Hamilton Avenue
                Suite 1102
                White Plains, NY 10601
             
        MINERVA GP, INC.
        Date: February 5, 2021
     
               
        By:   David P. Cohen
     
               
          By:   /s/ Beth N. Lowson
               
                Name: Beth N. Lowson
                Title: Attorney-In-Fact
                The Nelson Law Firm, LLC
                445 Hamilton Avenue
                Suite 1102 
                White Plains, NY 10601
             
        DAVID P. COHEN
        Date: February 5, 2021
     
               
          By:   /s/ Beth N. Lowson
               
                Name: Beth N. Lowson
                Title: Attorney-In-Fact
                The Nelson Law Firm, LLC
                445 Hamilton Avenue
                Suite 1102 
                White Plains, NY 10601


     

    POWER OF ATTORNEY
    The undersigned does hereby constitute and appoint Stephen J. Nelson, Mary Anne Mayo, and Beth N. Lowson, each of The Nelson Law Firm, LLC, One North Broadway, Suite 712, White Plains, NY 10601, signing singly, with full power of substitution, as the true and lawful attorney of the undersigned, and authorizes and designates each of them to sign on behalf of the undersigned, and to file filings and any amendments thereto made by or on behalf of the undersigned in respect of the beneficial ownership of equity securities held by the undersigned, directly, indirectly or beneficially, pursuant to Sections 13(d), 13(f), 13(g) and 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules and regulations thereunder. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned's responsibilities to comply with Sections 13(d), 13(f), 13(g) or 16 of the Exchange Act.
    This Power of Attorney shall remain in full force and effect until withdrawn by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 5th day of February, 2016.
         
    By: /s/ David P. Cohen
       
        David P. Cohen
         
         
         
         

     

    Get the next $INFU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INFU

    DatePrice TargetRatingAnalyst
    9/22/2025$15.00Buy
    Lake Street
    7/22/2025$12.00Buy
    Roth Capital
    9/26/2024$13.00Buy
    B. Riley Securities
    More analyst ratings

    $INFU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Eichenbaum Kenneth D. bought $10,360 worth of shares (2,000 units at $5.18), increasing direct ownership by 50% to 6,000 units (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    5/28/25 4:24:49 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    Director Hundzinski Ronald T bought $30,450 worth of shares (5,000 units at $6.09) (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    5/20/25 6:54:45 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    President and COO Lachance Carrie bought $18,987 worth of shares (3,132 units at $6.06), increasing direct ownership by 2% to 190,212 units (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    5/19/25 7:58:16 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026

    InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Centers for Medicare and Medicaid Services ("CMS") has added two of the electronic infusion pumps currently utilized by the Company within its Pain Management services business to the list of qualifying products for separate payment in conjunction with the Non-Opioids Prevent Addiction in the Nation ("NOPAIN") Act. The NOPAIN Act mandates that CMS provide separate payment for qualified non-opioid treatments through December 31, 2027 when provided wit

    12/10/25 5:37:00 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025

    InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today Carrie Lachance, President and Chief Executive Officer and Barry Steele, Chief Financial Officer, will participate in the 16th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 18, 2025. The conference will be held at the Sheraton New York Times Square Hotel in New York City. Management is scheduled to host in-person one-on-one meetings held throughout the day. Investors interested in arranging one-on-one meetings should contact your Craig-Hal

    11/10/25 4:30:00 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem Reports Third Quarter 2025 Financial Results

    Record Net Revenues of $36.5 million Representing 3% Growth from the Prior Year Net income of $2.3 million, up 25% Adjusted EBITDA (non-GAAP) of $8.3 million, up 6% Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to 23% Year-to-Date Net Operating Cash Flow of $17.3 million, up 38% Stock Repurchases totaled $2.2 million during third quarter Reaffirms Full-Year 2025 Guidance InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2025. 2025 Third Quarte

    11/4/25 6:30:00 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    SEC Filings

    View All

    InfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InfuSystem Holdings, Inc (0001337013) (Filer)

    12/10/25 5:23:42 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by InfuSystems Holdings Inc.

    SCHEDULE 13G - InfuSystem Holdings, Inc (0001337013) (Subject)

    12/3/25 1:41:24 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InfuSystem Holdings, Inc (0001337013) (Filer)

    11/13/25 4:30:46 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP-Chief HR Officer Funke Jerod converted options into 12,500 shares and covered exercise/tax liability with 3,669 shares, increasing direct ownership by 90% to 18,662 units (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    10/14/25 6:37:59 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    President and CEO Lachance Carrie was granted 50,000 shares and covered exercise/tax liability with 19,675 shares, increasing direct ownership by 15% to 232,174 units (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    9/25/25 4:27:56 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    Director Shuda Scott disposed of 2,242 shares and sold $55,622 worth of shares (5,752 units at $9.67), decreasing direct ownership by 8% to 94,000 units (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    8/22/25 5:33:54 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on InfuSystem with a new price target

    Lake Street resumed coverage of InfuSystem with a rating of Buy and set a new price target of $15.00

    9/22/25 8:45:41 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    Roth Capital initiated coverage on InfuSystem with a new price target

    Roth Capital initiated coverage of InfuSystem with a rating of Buy and set a new price target of $12.00

    7/22/25 7:53:05 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    B. Riley Securities initiated coverage on InfuSystem with a new price target

    B. Riley Securities initiated coverage of InfuSystem with a rating of Buy and set a new price target of $13.00

    9/26/24 7:35:18 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Leadership Updates

    Live Leadership Updates

    View All

    InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer

    The Company Reaffirms Full Year 2025 Guidance: Revenue Growth of 8-10% and Adjusted EBITDA (non-GAAP) margin greater than 18.8% InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced that Richard DiIorio will be stepping down as the Company's Chief Executive Officer, effective May 19, 2025. Concurrently, the Company announced that Carrie Lachance, the Company's President and Chief Operating Officer, and a member of the Company's board of directors, will assume the role of Chief Executive Officer effective May 19

    4/1/25 6:30:00 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem Appoints Ronald Hundzinski to the Board of Directors

    InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today the appointment of Ronald Hundzinski, as an independent director to InfuSystem's Board of Directors, effective November 12, 2024. Mr. Hundzinski will serve as a director until he stands for election at InfuSystem's next Annual Shareholders meeting in May 2025. Scott Shuda, Chairman of InfuSystem's Board of Directors, said, "We are pleased to welcome Ron to InfuSystem's Board. He adds both accounting and finance depth to our oversight and committee work and

    11/18/24 9:15:00 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors

    InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today the appointment of R. Rimmy Malhotra, a new independent director to InfuSystem's Board of Directors, effective September 20, 2022. Mr. Malhotra will serve as a director until he stands for election at InfuSystem's next Annual Shareholders meeting in May 2023. Scott Shuda, Chairman of InfuSystem's Board of Directors, said, "We are pleased to welcome Rimmy as a new independent director on InfuSystem's Board. Rimmy first invested in the Company in 2012, and has

    9/23/22 4:05:00 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Financials

    Live finance-specific insights

    View All

    InfuSystem Reports Third Quarter 2025 Financial Results

    Record Net Revenues of $36.5 million Representing 3% Growth from the Prior Year Net income of $2.3 million, up 25% Adjusted EBITDA (non-GAAP) of $8.3 million, up 6% Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to 23% Year-to-Date Net Operating Cash Flow of $17.3 million, up 38% Stock Repurchases totaled $2.2 million during third quarter Reaffirms Full-Year 2025 Guidance InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2025. 2025 Third Quarte

    11/4/25 6:30:00 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025

    Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2025 financial results on Tuesday, November 4, 2025, before the market opens. The Company will also conduct a conference call for all interested parties on Tuesday, November 4, 2025 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in t

    10/28/25 4:30:00 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem Reports Second Quarter 2025 Financial Results

    Record Net Revenues of $36.0 million Representing 7% Growth from the Prior Year Net income of $2.6 million, up 262% Adjusted EBITDA (non-GAAP) of $8.0 million, up 32% Adjusted EBITDA (non-GAAP) margin expanded by 4.3% to 22.3% Year-to-Date Net Operating Cash Flow of $8.8 million, up 227% Stock Repurchases totaled $3.5 million InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Overview: Net revenues totaled $36.0

    8/5/25 6:30:00 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by InfuSystems Holdings Inc.

    SC 13D/A - InfuSystem Holdings, Inc (0001337013) (Subject)

    12/9/24 6:38:13 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by InfuSystems Holdings Inc.

    SC 13D/A - InfuSystem Holdings, Inc (0001337013) (Subject)

    12/6/24 5:07:04 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by InfuSystems Holdings Inc.

    SC 13D/A - InfuSystem Holdings, Inc (0001337013) (Subject)

    9/24/24 2:06:02 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care